Xcout Intel
Atinary
Atinary is an artificial intelligence company with operations in Silicon Valley and Switzerland, featuring headquarters in Menlo Park, California. The company provides a code-free AI platform that accelerates research, development, and discovery in molecular science and chemistry.
Subscribe to see Atinary’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Atinary at a glance
Atinary is a deeptech company headquartered in United States. Its most recent funding round, Seed, raised $5M in October 2023. Xcout tracks 2 named people at Atinary, including Dr. Hermann Tribukait (Co-Founder & CEO).
Atinary leadership
- Dr. Hermann TribukaitCo-Founder & CEO
- Dr. Loïc RochCo-Founder & CTO
Atinary funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $5M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Atinary competitors
A few of Atinary's closest competitors — see the full list of competitors and alternatives →
AQEMIA is a French technology company that uses quantum-inspired algorithms and artificial intelligence for drug discovery. It develops therapeutic candidates and works with pharmaceutical and biotechnology companies to accelerate the design of new medicines.
Kebotix is a technology company founded in 2017 and headquartered in Cambridge, Massachusetts. The firm is dedicated to tackling major scientific challenges by leveraging advanced digital tools and artificial intelligence to revolutionize research and development in materials science.
Generare is a biotechnology and artificial intelligence company headquartered in Paris, France, focused on commercial bioprospecting and decoding natural products.
Variational AI is a privately held biotechnology startup headquartered in Vancouver, British Columbia. Founded in 2019, the company focuses on drug discovery, utilizing artificial intelligence to identify novel drug-like small molecules. Recognized as an innovative AI enterprise in Canada, it develops advanced computational methods for pharmaceutical research.
Altrove is an artificial intelligence startup headquartered in Paris, France. The company applies advanced physical and AI technologies to develop innovative materials and research solutions.
Mana.bio is an AI-based drug delivery startup headquartered in Tel Aviv, Israel, focusing on gene therapy and lipid nanoparticle development for mRNA and oligonucleotide therapeutics. The company leverages artificial intelligence to create advanced platforms for next-generation vaccines and genetic medicines.
Get Atinary's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Atinary in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access